{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-060582","form_type":"8-K","ticker":"ORKA","cik":"0000907654","company_name":"Oruka Therapeutics, Inc.","filed_at":"2021-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.164664+00:00","generated_at":"2026-06-28T00:44:33.320211+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"ARCA biopharma awards incentive stock options to four executives","bullets":["CEO Michael Bristow received 95,000 options; COO Keuer 35,000; GC Ozeroff 27,500; CFO Dekker 17,700.","Exercise price $2.29 per share, closing price on December 14, 2021; vesting in 36 equal monthly installments.","In a change of control, 50% of unvested options accelerate; remainder vest on earlier of one year or involuntary termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-060582","json":"https://secwatch.observer/filing/0001564590-21-060582.json","markdown":"https://secwatch.observer/filing/0001564590-21-060582.md","text":"https://secwatch.observer/filing/0001564590-21-060582.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/907654/000156459021060582/0001564590-21-060582-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/907654/000156459021060582/abio-8k_20211214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T00:44:33.320211+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}